Cannabinoids and experimental models of multiple sclerosis
- 1 August 2010
- journal article
- research article
- Published by Elsevier in Immunobiology
- Vol. 215 (8) , 647-657
Abstract
No abstract availableKeywords
This publication has 226 references indexed in Scilit:
- Endocannabinoids and immune regulation☆Pharmacological Research, 2009
- Evaluating potential therapies for bladder dysfunction in a mouse model of multiple sclerosis with high-resolution ultrasonographyMultiple Sclerosis Journal, 2009
- Cannabinoids, Endocannabinoids, and Related Analogs in InflammationThe AAPS Journal, 2009
- Hemopressin is an inverse agonist of CB 1 cannabinoid receptorsProceedings of the National Academy of Sciences, 2007
- Control of experimental autoimmune encephalomyelitis by CD4+ suppressor T cells: Peripheral versus in situ immunoregulationJournal of Neuroimmunology, 2007
- Control of Spasticity in a Multiple Sclerosis Model is mediated by CB1, not CB2, Cannabinoid ReceptorsBritish Journal of Pharmacology, 2007
- Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotectionProceedings of the National Academy of Sciences, 2006
- Cannabinoids in Microglia: A New Trick for Immune Surveillance and NeuroprotectionNeuron, 2006
- Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agentsBrain Research Reviews, 2003
- Cardiovascular effects of endocannabinoids—the plot thickensProstaglandins & Other Lipid Mediators, 2000